Stemtech (STEK) Tax Provisions (2021 - 2023)

Stemtech's (STEK) quarterly Tax Provisions came in at $33529.0 in Q3 2023, up 1675.9% quarter-over-quarter from $1888.0 in Q2 2023.

Stemtech (STEK) Tax Provisions (2021 - 2023) Analysis & Trends

Stemtech has disclosed Tax Provisions across 3 years of filings, most recently posting $33529.0 for Q3 2023.

Tax Provisions for Q3 2023 came in at $33529.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was $33529.0 (down 46.0% YoY), and the FY2022 annual result was $95618.0, changed N/A from the prior year.
Tax Provisions came in at $33529.0 for Q3 2023 at Stemtech, up from $1888.0 in the prior quarter.
In the past five years, Tax Provisions ranged from a high of $95618.0 in Q4 2022 to a low of -$35417.0 in Q1 2023.
The 3-year median for Tax Provisions is $1888.0 (2023), against an average of $19199.2.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	67.00 Mn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	157.00 Mn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	43.40 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-3.57 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	48.90 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	30.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	4.60 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	-9.44 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	37.99 Mn
10	Stemtech	-	-	354,677.00	-

Download Data